Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals - Wikidata - thesis-toulmin - TriplyDB

Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals

Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals

http://www.wikidata.org/entity/Q36018556

about

A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients.Effect of ginkgo biloba on the pharmacokinetics of raltegravir in healthy volunteers Comparison of the in vivo pharmacokinetics and in vitro dissolution of raltegravir in HIV patients receiving the drug by swallowing or by chewing.Clinical pharmacokinetics of antiretroviral drugs in older persons.P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.Pharmacogenetics of antiretroviral therapy.Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors.Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals.Variability of raltegravir plasma levels in the clinical setting.Precision medicine for HIV: where are we?

P2860

Q30431343-CD3A5834-B982-448F-9D35-9A0964705575 Q35125818-1182B42D-7336-49B0-8873-597DDF470447 Q36276907-6190A568-31F9-48F7-A40A-728715B29ED6 Q36396149-F4FA80F6-A5AD-40BB-9496-4B0E0AAC3201 Q36905884-B5453708-E986-451B-B23E-388C389BF641 Q37273923-7B9F7C85-12D3-407D-84CA-8743B709FDF9 Q38051400-FB9F5D31-AA10-41C0-A986-13B330FF7CC0 Q38221179-F99B73EB-FE6F-41AB-880D-CE05BE4D5E7F Q38868949-800F5D9D-F195-4FBB-A7D1-78C10B5A88E6 Q42215539-DAF3184E-B134-484D-8D7D-534165796AB8 Q42253719-6B3624E8-CEE2-4626-8FD5-653E9B3BBD87 Q47569821-ADE22409-CE0B-42DC-B91F-C5599E58BD20

P2860

Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals

http://www.wikidata.org/entity/Q36018556

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Population pharmacokinetic ana ...... sitive and healthy individuals

@ast

Population pharmacokinetic ana ...... sitive and healthy individuals

@en

type

label

Population pharmacokinetic ana ...... sitive and healthy individuals

@ast

Population pharmacokinetic ana ...... sitive and healthy individuals

@en

prefLabel

Population pharmacokinetic ana ...... sitive and healthy individuals

@ast

Population pharmacokinetic ana ...... sitive and healthy individuals

@en

P1433

Q36018556-40F02A2D-1068-4569-BA16-E0C83FF40DC7

P1476

Q36018556-F1D4EAAD-AD89-49D1-A6AB-780F4ECFC114

P2093

Q36018556-03A9A118-B8DC-4825-9400-207D8F382982

Q36018556-05CC2508-C868-44F1-99E4-A6A9FB614B50

Q36018556-0B0231CB-AE55-4F5A-91A2-C9ECCADD3888

Q36018556-1F155E8A-F270-47C1-8A9F-2F5237864DD6

Q36018556-36E30EDA-AD66-4470-AE47-73D60DBB557D

Q36018556-483CC3BB-3C92-4DB9-90FA-635E6504654C

Q36018556-5BE0CE09-A943-4AC1-99D6-5941D6FF82B4

Q36018556-6FD160DC-CEFB-448C-8C0C-7C3273D37B48

Q36018556-7B62BBF3-A079-4850-92D3-A5DF62F7996E

Q36018556-9519032D-7EF8-41B4-B42E-305EBBC81007

P2860

Q36018556-05AA5EB8-9915-4715-B5DA-74F1A60F7AF7

Q36018556-0E3DD07D-8958-4CA3-A7D2-A1BFBD962910

Q36018556-1214B218-4859-419A-AA8F-03FD6D4DEDFD

Q36018556-131348E8-BEAC-4897-8789-5598DD0E0602

Q36018556-18FE5C2D-B8C9-4087-9E81-7F25C9F4B149

Q36018556-1EC8E042-DA9F-4668-AC1B-83598D5823EB

Q36018556-20C0819C-49B6-470B-AFC8-D134BB2438A5

Q36018556-3B89F037-204C-4EE2-91CA-DC9C1B276551

Q36018556-42B4378C-EBFE-43BB-B4E9-E9D5DB36E61B

Q36018556-46B93006-10D8-4F1E-9591-099B7FDFABE5

P304

Q36018556-53CC5CC5-9542-404C-95F5-545906A38C43

P31

Q36018556-27A5FAD6-83FF-458C-B1AF-1442F254ECB1

P356

Q36018556-9A05CE47-2AA4-4E3F-A512-BC03CE911249

P407

Q36018556-D0330A85-5256-404B-8902-0254224CB59F

P433

Q36018556-7E9835AC-CA8D-4A50-A4B9-532FAAE88444

P478

Q36018556-4B7E9634-4BCA-404E-88D7-06A9A893B9EA

P50

Q36018556-3125EFD1-44B1-466B-A788-2B1CD64265C8

Q36018556-468ACB5D-3417-4394-B2B2-ACD196A3FB15

Q36018556-521FF89A-9CF0-4A64-843E-C087FBC78071

Q36018556-92A4A8A3-C217-4783-8633-7C6179B3BD86

Q36018556-97B8B2AA-1698-4021-8E69-F81170FBB385

Q36018556-A0AEA480-CF68-4BE1-9447-CC58B575BBA5

Q36018556-D49FF39D-DFB0-49DD-8406-00541E85D00C

P577

Q36018556-E465F533-AFF8-481A-A690-387B1093D64E

P698

Q36018556-A6ADD1D4-4CB0-40A0-82E3-BA4A283A3CBF

P932

Q36018556-EC4E4968-C941-48A7-A735-AB4A3E6AB41E

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Population pharmacokinetic ana ...... sitive and healthy individuals

@en

P2093

Amalio Telenti

http://www.w3.org/2001/XMLSchema#string

Aurélie Fayet-Mello

http://www.w3.org/2001/XMLSchema#string

Katharina Rentsch

http://www.w3.org/2001/XMLSchema#string

Manel Aouri

http://www.w3.org/2001/XMLSchema#string

Margalida Rotger

http://www.w3.org/2001/XMLSchema#string

Marta Boffito

http://www.w3.org/2001/XMLSchema#string

Michael Neely

http://www.w3.org/2001/XMLSchema#string

Mona Arab-Alameddine

http://www.w3.org/2001/XMLSchema#string

Rubin Lubomirov

http://www.w3.org/2001/XMLSchema#string

Swiss HIV Cohort Study Group

http://www.w3.org/2001/XMLSchema#string

P2860

PLINK: a tool set for whole-genome association and population-based linkage analyses

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

A New Statistical Method for Haplotype Reconstruction from Population Data

Efficiency and power in genetic association studies

A comparison of bayesian methods for haplotype reconstruction from population genotype data.

A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence.

Drug interactions with new and investigational antiretrovirals.

Predictability of the effects of race or ethnicity on pharmacokinetics of drugs.

Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteers.

Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population.

P304

2959-2966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.05424-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Huldrych F Günthard

Matthias Cavassini

Laurent Arthur Decosterd

P577

2012-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22371894

http://www.w3.org/2001/XMLSchema#string

P932

3370715

http://www.w3.org/2001/XMLSchema#string